开放期刊系统

高级别胶质瘤患者生命末期护理的临床研究

赵 丽, 黄 灵, 张 婷, 邹 瑜

摘要

目的:本研究旨在评估高级别胶质瘤(High-Grade Glioma,HGG)患 者生命末期(End of life,EOL)护理的临
床研究,以期为临床诊治提供参考。 方法:回顾性分析本院于 2020 年 1 月 -2023 年 1 月期间接受 HGG 转为姑息治疗 (PC)
患者 52 例,另选择未转诊至 PC 的 HGG 患者 (n=80) 和转诊为 PC 的非中枢神经系 统肿瘤患者 (n=80) 进行对比。根据预
先确定的变量计算每个患者在 EOL 医疗护理 积极程度的综合得分。当符合基于症状负担、功能状态和预后的预定标准时,
为 每个患者定义适合接受 PC 的时间。结果:在 HGG 转诊至 PC 的患者中,59.6%(N=31) 转诊为住院患者,53.8%(N=28)
转诊在生命最后 12 周内。无论 PC 转诊与否,HGG 患者在 EOL 有相似的积极护理,而 HGG 患者在 EOL 有比非中枢神
经系统癌症患者 更少的积极护理 (p=0.007)。在接受晚期 PC 转诊的 HGG 患者中,EOL 护理比早期 PC 转诊的患者更积
极 (p=0.012)。符合条件时运动无力 (OR=2.55,p=0.002) 和更 多的疾病进展 (OR=1.25,p=0.043) 与 EOL 较不积极的护理
相关。结论:早期临床 和疾病相关特征预测 HGG 患者在 EoL 进行积极的医疗护理,PC 在改善 HGG 患者 EoL 结局方面
的作用值得进一步评估。

关键词

高级别胶质瘤;生命末期护理;姑息治疗

全文:

PDF

参考

[1] Agar M R, Nowak A K, Hovey E J, et al. Acetazolamide

versus placebo for cerebral oedema requiring dexamethasone

in recurrent and/or progressive high-grade glioma: phase II

randomised placebo-controlled double-blind study[J]. BMJ

Support Palliat Care, 2023,13(3):354-362.

[2] Campbell R, Faris M, Shaw J, et al. Exploring the

clinical utility of a brief screening measure of unmet supportive

care needs in people with high-grade glioma[J]. Neurooncol Pract,

2023,10(5):454-461.

[3] Ciammella P, Cozzi S, Botti A, et al. Safety of

Inhomogeneous Dose Distribution IMRT for High-Grade Glioma

Reirradiation: A Prospective Phase I/II Trial (GLIORAD TRIAL)

[J]. Cancers (Basel), 2022,14(19).

[4] Crooms R C, Johnson M O, Leeper H, et al. Easing the

Journey-an Updated Review of Palliative Care for the Patient with

High-Grade Glioma[J]. Curr Oncol Rep, 2022,24(4):501-515.

[5] Crooms R C, Taylor J W, Jette N, et al. Palliative care

referral across the disease trajectory in high-grade glioma[J]. J

Neurooncol, 2023,163(1):249-259.

[6] Darcourt J, Chardin D, Bourg V, et al. Added value

of [(18)F]FDOPA PET to the management of high-grade glioma

patients after their initial treatment: a prospective multicentre

study[J]. Eur J Nucl Med Mol Imaging, 2023,50(9):2727-2735.

[7] Fontanilles M, Deniel A, Marguet F, et al. Usefulness

of circulating tumor DNA from cerebrospinal fluid in recurrent

high-grade glioma[J]. Rev Neurol (Paris), 2022,178(9):975-980.

[8] Glanz H, Damodharan S N, Smith-Simmer K, et al.

Concurrent high-grade glioma with cavernous malformations and

pathogenic variants in PDCD10 and SMARCA4[J]. Childs Nerv

Syst, 2023.

[9] Halkett G, Berg M N, Daudu D, et al. Supportive care

of patients diagnosed with high grade glioma and their carers in

Australia[J]. J Neurooncol, 2022,157(3):475-485.

[10] Halkett G, Lobb E A, Phillips J L, et al. Carer

preparedness improved by providing a supportive educational

intervention for carers of patients with high-grade glioma: RCT

results[J]. J Neurooncol, 2023,161(3):501-513.

[11] Han R H, Johanns T M, Roberts K F, et al. Diffusion

basis spectrum imaging as an adjunct to conventional MRI leads to

earlier diagnosis of high-grade glioma tumor progression versus

treatment effect[J]. Neurooncol Adv, 2023,5(1):d50.

[12] Huang V, Rejimon A, Reddy K, et al. Spectroscopic

MRI-Guided Proton Therapy in Non-Enhancing Pediatric HighGrade Glioma[J]. Tomography, 2023,9(2):633-646.

[13] Mirpuri P, Singh M, Rovin R A. The Association of

Preoperative Frailty and Neighborhood-Level Disadvantage with

Outcome in Patients with Newly Diagnosed High Grade Glioma[J].

World Neurosurg, 2022,166:e949-e957.

[14] Jones D, Pinkham M B, Wallen M P, et al. Benefits of

supportive strategies for carers of people with high-grade glioma:

a systematic review : Strategies for addressing the needs of highgrade glioma carers[J]. Support Care Cancer, 2022,30(12):10359-

10378.

[15] Kang J H, Desjardins A. Convection-enhanced delivery

for high-grade glioma[J]. Neurooncol Pract, 2022,9(1):24-34.

[16] Kang Z, Li S, Kang X, et al. Phase I study of chlorogenic

acid injection for recurrent high-grade glioma with long-term

follow-up[J]. Cancer Biol Med, 2023,20(6):465-476.

[17] Kassubek R, Lule D, Ludolph A C, et al. Bevacizumab

is associated with cerebral microstructural alterations: a DTI study

in high-grade glioma[J]. Front Neurol, 2023,14:1191226.

[18] 脑肿瘤合并糖尿病患者应用围手术期强化护理方案

的临床效果分析 [J]. 刘卫平 . 中国实用医药 .2018(16):161-163.

[19] 加速康复外科护理在脑质瘤患者围手术期的应用价

值 [J]. 王云钦、柯清仙 . 中国医药指南 .2024(06):153-156.

[20] 积极心理干预对青年脑卒中患者创伤后成长及主观

幸福感的影响 [J]. 程珍珍、周建梅、史文莉 . 中华现代护理

杂志 .2021(03):374-378.


(1 摘要 Views, 0 PDF Downloads)

Refbacks

  • 当前没有refback。